Sophie Janssens

Sophie Janssens has a diverse work experience spanning over several industries and roles. Sophie currently works at UCB as the Senior Vice President and Global Head of Early Patient Value Missions, a position they have held since January 2022. Prior to this role, they served as the Vice President and Global Head of Early Patient Value Missions at UCB from November 2019 to January 2022. Before that, they held the position of Vice President and Global Head of Real World Evidence from January 2017 to November 2019 at UCB. In addition, they have experience as the Vice President of Global Market Access and Pricing from February 2012 to January 2017, and as the Senior Director of Global Market Access and Pricing CNS from March 2011 to January 2012, both at UCB.

Sophie Janssens also has experience outside of UCB. Sophie served as a Board of Directors Observer at Aetion from January 2019 to May 2022. Prior to that, they worked as a Partner in Lifes Sciences & Health Care at Deloitte Consulting from September 2008 to February 2011. Their earlier roles include Geographic Principal Consulting & Services Benelux at IMS Health from May 2005 to July 2008, and Senior Manager at Deloitte from July 2003 to April 2005.

Before entering the private sector, Sophie Janssens worked in government roles. Sophie served as a Government negotiator & advisor at the Flemish government from July 1999 to June 2003, and as a Government advisor for the Federal government at the Chancellerie Prime Minister Belgium from July 1996 to August 1999.

Sophie Janssens attended Ghent University from 1987 to 1994. No specific degree or field of study was mentioned.